A Comparative Effectiveness Study of Major Glycemia-lowering Medications for Treatment of Type 2 Diabetes

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 7850 participants.

Also called NCT01794143

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Phase 3
Enrolled
  • 7,850 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT01794143
Main results
  • Comparative Effects of Glucose-Lowering Medications on Kidney Outcomes in Type 2 Diabetes: The GRADE Randomized Clinical Trial JAMA internal medicine, 2023-07-01 DOI, PubMed 37213109, PMC10203973 Not in the PMC Open Access subset.
Other papers using this trial's data
  • Association of Baseline Factors With Glycemic Outcomes in GRADE: A Comparative Effectiveness Randomized Clinical Trial Diabetes care, 2024-04-01 DOI, PubMed 38285957, PMC10973909 Not in the PMC Open Access subset.
  • Association of Hospitalizations With Randomized Glycemia-Lowering Treatment in GRADE Diabetes care, 2025-07-01 DOI, PubMed 40424051, PMC12178615 Not in the PMC Open Access subset.
  • Cardiovascular Outcomes in GRADE (Glycemia Reduction Approaches in Type 2 Diabetes: A Comparative Effectiveness Study) Circulation, 2024-03-26 DOI, PubMed 38344820, PMC10978227 In the PMC Open Access subset under a licence that is not Creative Commons.
  • Comparative Effects of Randomized Second-line Therapy for Type 2 Diabetes on a Composite Outcome Incorporating Glycemic Control, Body Weight, and Hypoglycemia: An Analysis of the Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness Study (GRADE) Diabetes care, 2024-04-01 DOI, PubMed 38194519, PMC10973908 Not in the PMC Open Access subset.
  • Differences in Prevalence and Incidence of Electrocardiogram Abnormalities and Cardiovascular Autonomic Neuropathy Among Randomized Glucose-Lowering Treatments in Early Type 2 Diabetes: The Glycemia Reduction Approaches in Diabetes (GRADE) Cohort Diabetes care, 2025-11-01 DOI, PubMed 40986645, PMC12583396 Not in the PMC Open Access subset.
  • Differential Treatment Effects on β-Cell Function Using Model-Based Parameters in Type 2 Diabetes: Results From the Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness Study (GRADE) Diabetes care, 2025-04-01 DOI, PubMed 39998948, PMC11932811 Not in the PMC Open Access subset.
  • Differential associations of somatic and cognitive-affective symptoms of depression with inflammation and insulin resistance: cross-sectional and longitudinal results from the Emotional Distress Sub-Study of the GRADE study Diabetologia, 2025-07 DOI, PubMed 39951058, PMC12176517 PubMed links an erratum for this paper. Erratum: PMID 40261357 In the PMC Open Access subset under CC BY.
  • Does Emotional Distress Predict Worse Glycemic Control Over Time? Results From the Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness Study (GRADE) Diabetes care, 2024-04-01 DOI, PubMed 38252848, PMC10973910 Not in the PMC Open Access subset.
  • Emotional Distress Predicts Reduced Type 2 Diabetes Treatment Adherence in the Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness Study (GRADE) Diabetes care, 2024-04-01 DOI, PubMed 38227900, PMC10973907 Not in the PMC Open Access subset.
  • Glucose-Lowering Medications, Glycemia, and Cognitive Outcomes: The GRADE Randomized Clinical Trial JAMA internal medicine, 2025-07-01 DOI, PubMed 40388190, PMC12090067 Not in the PMC Open Access subset.
  • Glycemia Reduction in Type 2 Diabetes - Glycemic Outcomes The New England journal of medicine, 2022-09-22 DOI, PubMed 36129996, PMC9829320 In the PMC Open Access subset under a licence that is not Creative Commons.
  • Glycemia Reduction in Type 2 Diabetes - Microvascular and Cardiovascular Outcomes The New England journal of medicine, 2022-09-22 DOI, PubMed 36129997, PMC9832916 In the PMC Open Access subset under a licence that is not Creative Commons.
  • Glycemia reduction in type 2 diabetes-Hypoglycemia outcomes: A randomized clinical trial PloS one, 2024 DOI, PubMed 39546502, PMC11567630 In the PMC Open Access subset under CC0.
  • Impact of Glucose-Lowering Medications on Health-Related Quality of Life in the Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness Study (GRADE) Diabetes care, 2024-04-01 DOI, PubMed 38190625, PMC10973906 Not in the PMC Open Access subset.
  • Impact of Insulin Sensitivity and β-Cell Function Over Time on Glycemic Outcomes in the Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness Study (GRADE): Differential Treatment Effects of Dual Therapy Diabetes care, 2024-04-01 DOI, PubMed 38190619, PMC10973903 Not in the PMC Open Access subset.
  • Lack of Association of Emotional Distress With Insulin Initiation in the GRADE Randomized Diabetes Comparative Effectiveness Trial The science of diabetes self-management and care, 2025-08 DOI, PubMed 40751289, PMC12403243 In the PMC Open Access subset under a licence that is not Creative Commons.
  • Longitudinal Effects of Glucose-Lowering Medications on β-Cell Responses and Insulin Sensitivity in Type 2 Diabetes: The GRADE Randomized Clinical Trial Diabetes care, 2024-04-01 DOI, PubMed 38211595, PMC10973918 Not in the PMC Open Access subset.
  • Optimization of Metformin in the GRADE Cohort: Effect on Glycemia and Body Weight Diabetes care, 2020-05 DOI, PubMed 32139384, PMC7171946 Not in the PMC Open Access subset.
  • Relationship Between Average Glucose Levels and HbA1c Differs Across Racial Groups: A Substudy of the GRADE Randomized Trial Diabetes care, 2024-12-01 DOI, PubMed 39312277, PMC11655407 Not in the PMC Open Access subset.
  • The Use of Rescue Insulin in the Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness Study (GRADE) Diabetes care, 2024-04-01 DOI, PubMed 37756542, PMC10973913 Not in the PMC Open Access subset.
  • The cross-sectional association of cognition with diabetic peripheral and autonomic neuropathy-The GRADE study Journal of diabetes and its complications, 2021-12 DOI, PubMed 34556408, PMC8608739 In the PMC Open Access subset under a licence that is not Creative Commons.
  • Use of comprehensive recruitment strategies in the glycemia reduction approaches in diabetes: A comparative effectiveness study (GRADE) multi-center clinical trial Clinical trials (London, England), 2023-10 DOI, PubMed 37329282, PMC10524662 In the PMC Open Access subset under a licence that is not Creative Commons.
  • Weight Gain Was Associated With Worsening Glycemia and Cardiovascular and Kidney Outcomes in Patients With Type 2 Diabetes Independent of Diabetes Medication in the GRADE Randomized Controlled Trial Diabetes care, 2025-06-01 DOI, PubMed 40267365, PMC12094209 Not in the PMC Open Access subset.

Courtesy of the U.S. National Library of Medicine.

Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
United States (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT01794143. Randomized; no masking; primary purpose treatment. Start 2013-05 (registry gives no type); primary completion 2021-04-30 (actual). Results posted on 2026-02-10.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
A Comparative Effectiveness Study of Major Glycemia-lowering Medications for Treatment of Type 2 Diabetes
Acronym
GRADE
Condition
Comparative Effectiveness of Glycemia-lowering Medications
Intervention (Drug)
Sulfonylurea (glimepiride)
Intervention (Drug)
DPP-4 inhibitor (sitagliptin)
Intervention (Drug)
GLP-1 receptor agonist (liraglutide)
Intervention (Drug)
Insulin (glargine)
Lead sponsor
GRADE Study Group (class: other)
Collaborator
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (class: US National Institutes of Health)
Collaborator
National Heart, Lung, and Blood Institute (NHLBI) (class: US National Institutes of Health)
Collaborator
Centers for Disease Control and Prevention (class: US federal agency)

Record details

Record id
cardio:ct-nct01794143
Content hash
cbee5d58bdd611dd2fb1f5b30a818a54fec9f04dea56845bea71f2441bc26a37